Explore our product offering by market:
We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications.
Human pharmaceuticals
We specialise in developing the highest quality and purest grades of pharmaceutical excipients, lipids and vaccine adjuvants to help you formulate seamlessly and drive your products to market. We tailor excipient purity to your needs.
We are committed to product quality, regulatory excellence, and supply chain security. We have worked with many pharma companies to bring COVID-19 vaccines and treatments to market faster, using our adjuvant and Super Refined™ excipients. While continuing to invest in expanding our portfolio and manufacturing footprint globally, quality is at the forefront of our plans.
Consumer Health
We combine our technical expertise with regulatory knowledge to help our customers market innovative products. We invent and reinvent ourselves to adapt to changing consumer needs and market trends.
Our main goal in Consumer Health is to help our customers market consumer relevant label claims that grow their product and brand authority.
Learn how we can help you grow your product brand by offering quality specialty ingredients developed for the OTC, oral hygiene, and human nutrition markets.
Veterinary Health
To serve the growing veterinary health market, we develop and commercialise a wide range of specialty excipients which are used to enhance the delivery, efficacy, and stability of actives in livestock and companion animal health products. Our broad portfolio also comprises adjuvants for the important veterinary vaccine market and extends further to omega-3 essential fatty acids for pet food products.
We collaborate with your formulation scientists to produce safer, more efficient, and highly specialised products that are used across a variety of marketed veterinary dosage forms. We strive to offer innovative solutions to meet the challenges formulators, veterinarians and livestock producers face every day.
Explore recent blogs:
Lipid Leaders: Söhnke Voss
In this Lipid Leaders interview, we speak to Söhnke Voss, PhD. Söhnke is a lipids expert with over 25 years’ experience in the pharmaceutical industry. Keep reading to learn more about lipids and the...
Read moreCroda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards
Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...
Read morePartnership agreement between Croda and AAHI to drive innovation in vaccine development
19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...
Read moreCroda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.
Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.
Read more